Materials and instrumentation
All reagents and starting materials were obtained from Sigma-Aldrich and Merck and were used as received without any further purification unless otherwise noted. X-ray powder diffraction (XRD) patterns were recorded using a Cu Kα radiation source on a D8
Advance Bruker powder diffractometer. Gas chromatographic (GC) analyses were performed using a Shimadzu GC 2010-Plus equipped with a flame ionization detector (FID) and an SPB-5 column (length = 30 m, inner diameter = 0.25 mm, and film thickness = 0.25 μm). In the GC temperature program, the sample of the reaction was held at 100 °C for 1 min, heated from 100 to 280 °C at 40 o C/min, and held at 280 °C for 6.5 min. GC yields of the reaction were calculated using diphenyl ether internal standard.
GC-MS analyses were performed using a Shimadzu GCMS-QP2010Ultra with a ZB-5MS column (length = 30 m, inner diameter = 0.25 mm, and film thickness = 0.25 μm).
The temperature program for GC-MS analysis held samples at 50 °C for 2 min, heated samples from 50 to 280 °C at 10 °C/min, and held them at 280 °C for 10 min. Inlet temperature was set constant at 280 o C. The spectra were compared with that gathered in the NIST library. The 1 H, 13 C, and 19 F spectra were recorded on Bruker AV 500, JEOL EC-400, or JEOL EC-600 spectrometers using residual solvent peaks as references.
Experimental and results

General procedure
To a pressurized vial was charged trans-chalcone (62 mg, 0.3 mmol), 2-aminopyrimidine (48 mg, 0.5 mmol), I 2 (254 mg, 0.6 mmol), CuFe 2 O 4 , diphenyl ether (51 mg, 0.3 mmol) internal standard, and 1,4-dioxane (2.5 mL). The vial was heated at 140 °C for 7 h under an oxygen atmosphere. The reaction progress was monitored by withdrawing an aliquot of the reaction mixture and quenching with Na 2 S 2 O 3 solution (10% v/v, 1 mL). Organic compounds then were extracted with ethyl acetate (2 mL x 2). Combined organic phases were dried over Na 2 SO 4 , filtered, and concentrated. Purification by column chromatography afforded desire products.
Product characterization
Phenyl(2-phenylimidazo[1,2-a]pyrimidin-3-yl)methanone (1 , Table 1 1 H NMR (500 MHz, CDCl 3 , ppm) δ 9.77 (dd, J = 6.9, 2.0 Hz, 1H), 8.81 (dd, J = 4.2, 2.1 Hz, 1H), 7.52 (dd, J = 8.2, 1.2 Hz, 2H), 7. 2H), 7.30 (dt, J = 8.7, 1.2 Hz, 1H), 2H), 4H) . 1 X. Meng, J. Zhang, B. Chen, Z. Jing, P. Zhao, Catal. Sci. Technol. 2016, 6, 890. 132.2, 130.5, 129.6, 128.8, 127.9, 127.8, 118.2, 110.8. (2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl)(phenyl)methanone (entry 1, 55 -7.49 (m, 2H), 7.40 -7.35 (m, 1H), 7.35 -7.32 (m, 2H), 7.20 -7.14 (m, 3H), 7.11 -7.06 (m, 2H) .
13 C NMR (126 MHz, CDCl 3 , ppm) δ 187. 3, 154.5, 153.7, 150.0, 137.9, 136.0, 135.1, 132.5, 131.7, 131.7, 129.6, 128.2, 128.1, 118.2, 110.9 .
Phenyl(2-phenylimidazo[1,2-a]pyridin-3-yl)methanone (entry 2, 4, 154.9, 147.4, 138.6, 133.9, 131.8, 130.2, 129.6, 129.3, 128.3, 127.8, 120.0, 117.5, 114.7 . Two carbon signals could not be located.
(2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-yl)(phenyl)methanone (entry 3, 153.6, 147.5, 138.6, 134.5, 132.6, 132.0, 131.4, 129.6, 129.4, 128.3, 128.0, 120.1, 117.5, 114.8 . One carbon signal could not be located. 4, 159.8, 154.8, 147.5, 138.7, 131.7, 131.6, 129.6, 129.1, 128.3, 127.8, 126.5, 119.7, 117.3, 114.4, 113.3, 55 .3. 3, 154.7, 146.3, 138.8, 134.0, 132.2, 131.7, 130.2, 129.6, 128.2, 127.7, 126.2, 124.7, 119.9, 116.7, 18 .5. One carbon signal could not be located. 9, 153.9, 147.9, 141.1, 138.8, 134.4, 132.8, 131.8, 131.4, 129.5, 127.9, 127.5, 117.3, 116.1, 89.7, 21.6 . One carbon signal could not be located. 3, 154.9, 146.5, 138.8, 134.2, 132.1, 131.7, 130.2, 129.6, 128.1, 127.71, 127.70, 126.2, 124.6, 119.9, 116.7, 18 .5. 4, 159.6, 154.7, 146.4, 138.8, 132.1, 131.6, 131.5, 129.6, 127.8, 126.6, 126.2, 124.4, 119.6, 116.5, 113.3, 55.2, 18 .5. 4, 159.9, 154.9, 145.7, 138.2, 132.0, 131.5, 130.3, 129.6, 127.9, 126.2, 126.0, 122.6, 119.9, 117.5, 113.4, 55.3 . 4, 159.8, 154.8, 147.4, 138.7, 131.7, 131.5, 129.6, 129.1, 128.2, 127.8, 126.5, 119.7, 117.3, 114.4, 113.3, 55 .2. 2, 129.5, 128.5, 128.3, 127.9, 126.5, 119.9, 117.6, 114.8 . Nitrophenyl)(2-phenylimidazo[1,2-a]pyridin-3-yl) signal), 7.22 -7.13 (m, 2H), 7.09 (t, J = 7.5 Hz, 2H).
(4-
13 C NMR (126 MHz, CDCl 3 , ppm) δ 184. 7, 156.4, 149.0, 148.0, 144.3, 133.6, 130.3, 130.23, 130.19, 129.0, 128.6, 128.0, 122.8, 119.9, 117.7, 115.4 . Hz, 1H).
13 C NMR (126 MHz, CDCl 3 ) δ 150. 3, 145.2, 131.9, 130.9, 130.2, 130.1, 128.7, 128.2, 126.1, 118.3, 116.5 . Fig. S12 13 C spectrum of (7-methyl-2-phenylimidazo[1,2-a]pyridin-3-yl)(phenyl)methanone.
Fig. S13
1 H spectrum of (7-methyl-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)(phenyl)methanone.
Fig. S14
13 C spectrum of (7-methyl-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)(phenyl)methanone.
Fig. S15
1 H spectrum of (7-methyl-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)(phenyl)methanone.
Fig. S16 13 C spectrum of (7-methyl-2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)(phenyl)methanone.
Fig. S17
1 H spectrum of (6-methyl-2-phenyl)imidazo[1,2-a]pyridin-3-yl)(phenyl)methanone.
Fig. S18
13 C spectrum of (6-methyl-2-phenyl)imidazo[1,2-a]pyridin-3-yl)(phenyl)methanone. 
